Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priya Rastogi

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Menopause (New York, N.Y.)|August 14, 2008
Chemoprevention in postmenopausal womenPriya Rastogi
Oncology (Williston Park, N.Y.)|July 9, 2003
Update on breast cancer preventionPriya Rastogi, Victor G Vogel
Statistics in Medicine|September 29, 2018
Assessment of effect size and power for survival analysis through a binary surrogate endpoint in clinical trialsJudah Abberbock, Stewart Anderson, Priya Rastogi, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Drug development: neoadjuvant opportunities in breast cancerPriya Rastogi, Charles E Geyer, Eleftherios P Mamounas, et al.
Oncology Nursing Forum|December 28, 2010
The attitudes, communication, treatment, and support intervention to reduce breast cancer treatment disparityMargaret Rosenzweig, Adam Brufsky, Priya Rastogi, et al.
The Oncologist|January 14, 2018
Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014Mary C Schroeder, Priya Rastogi, Charles E Geyer, et al.
Chinese Clinical Oncology|March 14, 2017
Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP)Priya Rastogi, D Lawrence Wickerham, Charles E Geyer, et al.
Journal of the National Cancer Institute|August 11, 2024
Long-term outcomes by lobular vs ductal histology in 4 National Surgical Adjuvant Breast and Bowel Project adjuvant breast cancer trialsJulia Foldi, Neil Carleton, Stewart J Anderson, et al.
Future Oncology (London, England)|June 25, 2026
EMPIRE (NSABP FC-13): a biomarker-driven phase II platform trial evaluating cemiplimab-based immunotherapy in microsatellite-stable colorectal cancer with ctDNA-defined minimal residual diseaseAnwaar Saeed, Greg Yothers, Shannon L Puhalla, et al.
The Journal of Supportive Oncology|June 17, 2008
What do perceived cognitive problems reflect?Catherine M Bender, Maria L Pacella, Susan M Sereika, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Menopause (New York, N.Y.)|August 14, 2008
Chemoprevention in postmenopausal womenPriya Rastogi
Oncology (Williston Park, N.Y.)|July 9, 2003
Update on breast cancer preventionPriya Rastogi, Victor G Vogel
Statistics in Medicine|September 29, 2018
Assessment of effect size and power for survival analysis through a binary surrogate endpoint in clinical trialsJudah Abberbock, Stewart Anderson, Priya Rastogi, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Drug development: neoadjuvant opportunities in breast cancerPriya Rastogi, Charles E Geyer, Eleftherios P Mamounas, et al.
Oncology Nursing Forum|December 28, 2010
The attitudes, communication, treatment, and support intervention to reduce breast cancer treatment disparityMargaret Rosenzweig, Adam Brufsky, Priya Rastogi, et al.
The Oncologist|January 14, 2018
Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014Mary C Schroeder, Priya Rastogi, Charles E Geyer, et al.
Chinese Clinical Oncology|March 14, 2017
Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP)Priya Rastogi, D Lawrence Wickerham, Charles E Geyer, et al.
Journal of the National Cancer Institute|August 11, 2024
Long-term outcomes by lobular vs ductal histology in 4 National Surgical Adjuvant Breast and Bowel Project adjuvant breast cancer trialsJulia Foldi, Neil Carleton, Stewart J Anderson, et al.
Future Oncology (London, England)|June 25, 2026
EMPIRE (NSABP FC-13): a biomarker-driven phase II platform trial evaluating cemiplimab-based immunotherapy in microsatellite-stable colorectal cancer with ctDNA-defined minimal residual diseaseAnwaar Saeed, Greg Yothers, Shannon L Puhalla, et al.
The Journal of Supportive Oncology|June 17, 2008
What do perceived cognitive problems reflect?Catherine M Bender, Maria L Pacella, Susan M Sereika, et al.
Pageof 9